Bright Light Therapy in Seasonal Affective Disorder (SAD)
Finland60 participantsStarted 2009-10
Plain-language summary
The aim of this study is to investigate the efficacy of bright light therapy in SAD. This is a placebo-controlled, double-blind randomized controlled trial (RCT).
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* a patient has, according to the DSM-IV-TR, a Major depression, recurrent episode, seasonal pattern, "moderate" or "severe" (classification code 296.32 and 296.33)
* HAMD-21 (included in the SIGH-SAD) sum score is ≥ 22
* patient is over 18 years
* patient can read and understand the subject information sheet
* patient has signed the informed consent form
* patient is not pregnant
Exclusion Criteria:
* patient has a lifetime psychotic disorder
* patient has a DSM-IV Axis I disorder other than some anxiety disorder evaluated by MINI
* patient has some DSM-IV-TR Axis II disorder, which is likely to interfere with the study treatment according to the investigator
* patient has alcohol or some other substance use dependence or misuse
* life-time suicide attempt, or any thought of suicide during the last month
* patients has some unstable somatic disorder
* patient uses some medication on regular basis
* patient uses some herbal psychotropic agencies
* patient is, in the opinion of the investigator, unsuitable for any reason
* patient is a member of the site personnel or their immediate families
* patient has had bright light therapy during the current episode
* patient has some eye disease (patient can, however, be myopic or hyperopic)
What they're measuring
1
Remission as defined by the SIGH-SAD
Timeframe: 28 (visit window from 26 to 30 days) days after the inclusion day